Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agios Pharmaceuticals (AGIO) Depreciation and Depletion: 2011-2024

Historic Depreciation and Depletion for Agios Pharmaceuticals (AGIO) over the last 14 years, with Dec 2024 value amounting to $5.7 million.

  • Agios Pharmaceuticals' Depreciation and Depletion rose 19.39% to $2.4 million in Q2 2020 from the same period last year, while for Jun 2020 it was $8.9 million, marking a year-over-year increase of 13.96%. This contributed to the annual value of $5.7 million for FY2024, which is 13.64% down from last year.
  • Per Agios Pharmaceuticals' latest filing, its Depreciation and Depletion stood at $5.7 million for FY2024, which was down 13.64% from $6.6 million recorded in FY2023.
  • In the past 5 years, Agios Pharmaceuticals' Depreciation and Depletion registered a high of $9.4 million during FY2020, and its lowest value of $5.7 million during FY2024.
  • Over the past 3 years, Agios Pharmaceuticals' median Depreciation and Depletion value was $6.6 million (recorded in 2023), while the average stood at $6.9 million.
  • Per our database at Business Quant, Agios Pharmaceuticals' Depreciation and Depletion climbed by 17.50% in 2020 and then decreased by 21.43% in 2023.
  • Over the past 5 years, Agios Pharmaceuticals' Depreciation and Depletion (Yearly) stood at $9.4 million in 2020, then fell by 6.38% to $8.8 million in 2021, then dropped by 4.55% to $8.4 million in 2022, then decreased by 21.43% to $6.6 million in 2023, then decreased by 13.64% to $5.7 million in 2024.